ABMT (Advanced BioMedical Technologies) EBITDA Margin %: 0.00% (As of Jul. 2021)


What is Advanced BioMedical Technologies EBITDA Margin %?

Advanced BioMedical Technologies ABMT EBITDA Margin % is 0.00% as of Jul. 2021.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Advanced BioMedical Technologies's EBITDA for the three months ended in Jul. 2021 was $-0.11 Mil. Advanced BioMedical Technologies's Revenue for the three months ended in Jul. 2021 was $0.00 Mil. Therefore, Advanced BioMedical Technologies's EBITDA margin for the quarter that ended in Jul. 2021 was 0.00%.

Advanced BioMedical Technologies  (OTCPK:ABMT) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Advanced BioMedical Technologies EBITDA Margin % Related Terms

Advanced BioMedical Technologies EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Advanced BioMedical Technologies's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advanced BioMedical Technologies EBITDA Margin % Chart

Advanced BioMedical Technologies Annual Data
Trend Oct11 Oct12 Oct13 Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -5,008.33 -228.23

Advanced BioMedical Technologies Quarterly Data
Oct16 Jan17 Apr17 Jul17 Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10,700.00 -112.90 -168.09 0.00 0.00

ABMT vs VYCO, ADMT, THMO: EBITDA Margin % Comparison

For the Medical Devices subindustry, Advanced BioMedical Technologies's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Advanced BioMedical Technologies EBITDA Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Advanced BioMedical Technologies's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Advanced BioMedical Technologies's EBITDA Margin % falls into.


Advanced BioMedical Technologies EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Advanced BioMedical Technologies's EBITDA Margin % for the fiscal year that ended in Oct. 2020 is calculated as

EBITDA Margin %=EBITDA (A: Oct. 2020 )/Revenue (A: Oct. 2020 )
=-0.283/0.124
=-228.23 %

Advanced BioMedical Technologies's EBITDA Margin % for the quarter that ended in Jul. 2021 is calculated as

EBITDA Margin %=EBITDA (Q: Jul. 2021 )/Revenue (Q: Jul. 2021 )
=-0.11/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
Advanced BioMedical Technologies (ABMT) has a EBITDA Margin % of 0.00% as of Jul. 2021. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Advanced BioMedical Technologies and its competitors.
Is Advanced BioMedical Technologies' EBITDA Margin % too high?
Advanced BioMedical Technologies' current EBITDA Margin % is 0.00%.
How does Advanced BioMedical Technologies' EBITDA Margin % compare to VYCO and ADMT?
Advanced BioMedical Technologies' EBITDA Margin % of 0.00% can be compared against companies in the Medical Devices & Instruments industry. The industry median EBITDA Margin % is 7.44. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.44, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Advanced BioMedical Technologies and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Advanced BioMedical Technologies's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced BioMedical Technologies stock overvalued right now?
Advanced BioMedical Technologies (ABMT) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Advanced BioMedical Technologies (ABMT), the current EBITDA Margin % is 0.00% as of Jul. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Advanced BioMedical Technologies Business Description

Address 535 Fifth Avenue, 4th Floor, New York, NY, USA, 10017
Advanced BioMedical Technologies Inc is engaged in designing, developing, manufacturing, and the planned future marketing of self-reinforced, re-absorbable, biodegradable internal fixation devices. The company manufactures its products using Polyamide, and it is used in a variety of applications, which include orthopaedic trauma, sports-related medical treatment, cartilage injuries, and reconstructive dental procedures. Its Polyamide products include screws, rods, and binding wires consisting of enhanced fibres and high molecular polymers, which are designed to facilitate quick healing of complex fractures in many areas of the human skeletal system.